RUA Life Sciences (LON:RUA) Shares Down 9.7% – Should You Sell?

RUA Life Sciences plc (LON:RUAGet Free Report)’s stock price dropped 9.7% during mid-day trading on Tuesday . The company traded as low as GBX 21.08 and last traded at GBX 21.08. Approximately 98,450 shares traded hands during trading, a decline of 63% from the average daily volume of 264,659 shares. The stock had previously closed at GBX 23.36.

RUA Life Sciences Stock Down 1.7%

The stock has a 50 day moving average price of GBX 16.87 and a 200-day moving average price of GBX 14.48. The stock has a market capitalization of £12.82 million, a P/E ratio of -2.61 and a beta of 0.97. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32.

About RUA Life Sciences

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Featured Stories

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.